Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model

Journal of Alzheimer's Disease

Volumn 56, Issue 2, 2017, Pages 775-788

  Brandscheid, Carolin ^a   Schuck, Florian ^a   Reinhardt, Sven ^a   Schäfer, Karl Herbert ^b   Pietrzik, Claus U ^a   Grimm, Marcus ^c   Hartmann, Tobias ^c   Schwiertz, Andreas ^d   Endres, Kristina ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES KAISERSLAUTERN   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d MVZ Institut für Mikroökologie GmbH   (Germany)

Author keywords

Alzheimer's disease; gut; microbiome; trypsin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; RNA 16S; TRYPSIN; APP PROTEIN, HUMAN; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; FECES ANALYSIS; FEMALE; FLUOROMETRY; FOOD INTAKE; GENE OVEREXPRESSION; INTESTINE FLORA; LOCOMOTION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WEIGHT REDUCTION; WESTERN BLOTTING; WILD TYPE; AGING; ANIMAL; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; COLON; DISEASE MODEL; EATING; ENZYMOLOGY; FECES; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BODY WEIGHT; COLON; DISEASE MODELS, ANIMAL; EATING; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRESENILIN-1; TRYPSIN;

EID: 85011343828     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160926     Document Type: Article

References (70)

1. Foster JA, McVey Neufeld KA (2013) Gut-brain axis: How the microbiome influences anxiety and depression. Trends Neurosci 36, 305-312.
2. Diaz HR, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S (2011) Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 108, 3047-3052.
3. Neufeld KA, Kang N, Bienenstock J, Foster JA (2011) Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol 4, 492-494.
4. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG (2008) The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res 43, 164-174.
5. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108, 16050-16055.
6. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain-Raspaud S, Trotin B, Naliboff B, Mayer EA (2013) Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144, 1394-1401.
7. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451-1463.
8. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Backhed F, Mithieux G (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84-96.
9. Thomas RH, MeekingMM, Mepham JR, Tichenoff L, Possmayer F, Liu S, MacFabe DF (2012) The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: Further development of a rodent model of autism spectrum disorders. J Neuroinflammation 9, 153.
10. Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA (2013) Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism 4, 42.
11. Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8, e68322.
12. Gabrielli M, Bonazzi P, Scarpellini E, Bendia E, Lauritano EC, Fasano A, Ceravolo MG, Capecci M, Rita BA, Provinciali L, Tonali PA, Gasbarrini A (2011) Prevalence of small intestinal bacterial overgrowth in Parkinson's disease. Mov Disord 26, 889-892.
13. Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Burmann J, Fassbender K, Schwiertz A, Schafer KH (2016) Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat Disord 32, 66-72.
14. Braak H, de Vos RA, Bohl J, Del TK (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett 396, 67-72.
15. Sherwin E, Sandhu KV, Dinan TG, Cryan JF (2016) May the force be with you: The light and dark sides of the microbiota-gut-brain axis in neuropsychiatry. CNS Drugs 30, 1019-1041.
16. Hill JM, Clement C, Pogue AI, Bhattacharjee S, Zhao Y, Lukiw WJ (2014) Pathogenic microbes, the microbiome, and Alzheimer's disease (AD). Front Aging Neurosci 6, 127.
17. Joachim CL, Mori H, Selkoe DJ (1989) Amyloid betaprotein deposition in tissues other than brain in Alzheimer's disease. Nature 341, 226-230.
18. Arai H, Lee VM, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ (1991) Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann Neurol 30, 686-693.
19. Semar S, Klotz M, Letiembre M, Van GC, Braun A, Jost V, Bischof M, Lammers WJ, LiuY, Fassbender K, Wyss-Coray T, Kirchhoff F, Schafer KH (2013) Changes of the enteric nervous system in amyloid-beta protein precursor transgenic mice correlate with disease progression. J Alzheimers Dis 36, 7-20.
20. White H, Pieper C, Schmader K (1998) The association of weight change in Alzheimer's disease with severity of disease and mortality: Alongitudinal analysis. J AmGeriatr Soc 46, 1223-1227.
21. White H, Pieper C, Schmader K, Fillenbaum G (1997) A longitudinal analysis of weight change in Alzheimer's disease. J Am Geriatr Soc 45, 531-532.
22. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P (2003) Body mass index and incidence of dementia: The PAQUID study. Neurology 60, 117-119.
23. Doty RL (1989) Influence of age and age-related diseases on olfactory function. Ann N Y Acad Sci 561, 76-86.
24. Stewart R, Masaki K, Xue QL, Peila R, Petrovitch H, White LR, Launer LJ (2005)A32-year prospective study of change in body weight and incident dementia: The Honolulu-Asia Aging Study. Arch Neurol 62, 55-60.
25. Johnson DK, Wilkins CH, Morris JC (2006) Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol 63, 1312-1317.
26. Knopman DS, Edland SD, Cha RH, Petersen RC, RoccaWA (2007) Incident dementia in women is preceded by weight loss by at least a decade. Neurology 69, 739-746.
27. Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, Langbaum JB, Ayutyanont N, Roontiva A, Thiyyagura P, LeeW, MoH, Lopez L, Moreno S, Acosta-Baena N, Giraldo M, Garcia G, Reiman RA, Huentelman MJ, Kosik KS, Tariot PN, Lopera F, Reiman EM (2012) Florbetapir PET analysis of amyloid-beta deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional study. Lancet Neurol 11, 1057-1065.
28. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van EL, Berry R, VassarR(2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. J Neurosci 26, 10129-10140.
29. Storck SE, Meister S, Nahrath J, Meissner JN, Schubert N, Di SA, Baches S, Vandenbroucke RE, Bouter Y, Prikulis I, Korth C, Weggen S, Heimann A, Schwaninger M, Bayer TA, Pietrzik CU (2016) Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier. J Clin Invest 126, 123-136.
30. Clapcote SJ, Roder JC (2005) Simplex PCR assay for sex determination in mice. Biotechniques 38, 702, 704, 706.
31. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
32. Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, Forslund K, Hildebrand F, Prifti E, Falony G, Le CE, Levenez F, Dore J, Mattila I, Plichta DR, Poho P, Hellgren LI, Arumugam M, Sunagawa S, Vieira-Silva S, Jorgensen T, Holm JB, Trost K, Kristiansen K, Brix S, Raes J, Wang J, Hansen T, Bork P, Brunak S, Oresic M, Ehrlich SD, PedersenO(2016) Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535, 376-381.
33. Sokol H, Lepage P, Seksik P, Dore J, Marteau P (2006) Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol 44, 3172-3177.
34. Henkin RI, Martin BM, Agarwal RP (1999) Decreased parotid saliva gustin/carbonic anhydrase VI secretion: An enzyme disorder manifested by gustatory and olfactory dysfunction. Am J Med Sci 318, 380-391.
35. Patrikainen M, Pan P, Kulesskaya N, Voikar V, Parkkila S (2014) The role of carbonic anhydrase VI in bitter taste perception: Evidence from the Car6(-)/(-) mouse model. J Biomed Sci 21, 82.
36. Oleksiewicz MB, Kjeldal HO, Kleno TG (2005) Identification of stool proteins in C57BL/6J mice by two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry. Biomarkers 10, 29-40.
37. Serquiz AC, Machado RJ, Serquiz RP, Lima VC, de Carvalho FM, Carneiro MA, Maciel BL, Uchoa AF, Santos EA, Morais AH (2016) Supplementation with a new trypsin inhibitor from peanut is associated with reduced fasting glucose, weight control, and increased plasmaCCKsecretion in an animal model. J Enzyme Inhib Med Chem 31, 1261-1269.
38. Donovan MJ, Paulino G, Raybould HE (2007) CCK(1) receptor is essential for normal meal patterning in mice fed high fat diet. Physiol Behav 92, 969-974.
39. Goto K, Kato G, Kawahara I, Luo Y, Obata K, Misawa H, Ishikawa T, Kuniyasu H, Nabekura J, Takaki M (2013) In vivo imaging of enteric neurogenesis in the deep tissue of mouse small intestine. PLoS One 8, e54814.
40. Stine Jr WB, Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278, 11612-11622.
41. Chander H, Chauhan A, Wegiel J, Malik M, Sheikh A, Chauhan V (2006) Binding of trypsin to fibrillar amyloid beta-protein. Brain Res 1082, 173-181.
42. Gu S, Chen D, Zhang JN, Lv X, Wang K, Duan LP, Nie Y, Wu XL (2013) Bacterial community mapping of the mouse gastrointestinal tract. PLoS One 8, e74957.
43. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24, 1063-1070.
44. Sadleir KR, Eimer WA, Cole SL, Vassar R (2015) Abeta reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Mol Neurodegener 10, 1.
45. Yurkovetskiy L, Burrows M, Khan AA, Graham L, Volchkov P, Becker L, Antonopoulos D, Umesaki Y, Chervonsky AV (2013) Gender bias in autoimmunity is influenced by microbiota. Immunity 39, 400-412.
46. Shatzman AR, Henkin RI (1981) Gustin concentration changes relative to salivary zinc and taste in humans. Proc Natl Acad Sci U S A 78, 3867-3871.
47. Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van LF (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274, 6483-6492.
48. Stevenson KS, McGlynn L, Hodge M, McLinden H, George WD, Davies RW, Shiels PG (2009) Isolation, characterization, and differentiation of thy1. 1-sorted pancreatic adult progenitor cell populations. Stem Cells Dev 18, 1389-1398.
49. Adebakin A, Bradley. J, Gumusgoz S, Waters EJ, Lawrence CB (2012) Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer's disease mouse model. PLoS One 7, e45179.
50. Bannerman PG, Mirsky R, Jessen KR (1988) Establishment and properties of separate cultures of enteric neurons and enteric glia. Brain Res 440, 99-108.
51. Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM, Bruneau BG, Giasson BI, Smeyne RJ, Gershon MD, Nussbaum RL (2010) Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet 19, 1633-1650.
52. Puig KL, Lutz BM, Urquhart SA, Rebel AA, Zhou X, Manocha GD, Sens M, Tuteja AK, Foster NL, Combs CK (2015) Overexpression of mutant amyloid-beta protein precursor and presenilin 1 modulates enteric nervous system. J Alzheimers Dis 44, 1263-1278.
53. Chauhan V, Sheikh AM, Chauhan A, Spivack WD, Fenko MD, Malik MN (2005) Fibrillar amyloid beta-protein inhibits the activity of high molecular weight brain protease and trypsin. J Alzheimers Dis 7, 37-44.
54. Galloway S, Takechi R, Pallebage-GamarallageMM, Dhaliwal SS, Mamo JC (2009) Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine. Lipids Health Dis 8, 46.
55. Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y (2011) Molecular analysis of the luminal-and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 301, G799-G807.
56. Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR (2010) A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 55, 392-397.
57. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
58. Abdallah IN, Ragab SH, Abd EA, Shoeib AR, Alhosary Y, Fekry D (2011) Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults. Arch Med Sci 7, 501-507.
59. Preidis GA, Ajami NJ, Wong MC, Bessard BC, Conner ME, Petrosino JF (2016) Microbial-derived metabolites reflect an altered intestinal microbiota during catch-up growth in undernourished neonatal mice. J Nutr 146, 940-948.
60. Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, e9505.
61. Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani. J, Lefkowitz A, McColl G, Goldstein LE, Tanzi RE, Moir RD (2016) Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med 8, 340ra372.
62. Spitzer P, Condic M, Herrmann M, Oberstein TJ, Scharin-Mehlmann M, Gilbert DF, Friedrich O, Gromer T, Kornhuber. J, Lang R, Maler JM (2016) Amyloidogenic amyloid-beta-peptide variants induce microbial agglutination and exert antimicrobial activity. Sci Rep 6, 32228.
63. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341.
64. van de Haar HJ, Burgmans S, Jansen JF, van Osch MJ, van Buchem MA, Muller M, Hofman PA, Verhey FR, Backes WH (2016) Blood-brain barrier leakage in patients with early Alzheimer disease. Radiology 281, 527-535.
65. Soenen S, Rayner CK, Jones KL, Horowitz M (2016) The ageing gastrointestinal tract. Curr Opin Clin Nutr Metab Care 19, 12-18.
66. Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85, 296-302.
67. Tran L, Greenwood-VanMB(2013) Age-associated remodeling of the intestinal epithelial barrier. J Gerontol A Biol Sci Med Sci 68, 1045-1056.
68. Zhao Y, Dua P, Lukiw WJ (2015) Microbial sources of amyloid and relevance to amyloidogenesis and Alzheimer's disease (AD). J Alzheimers Dis Parkinsonis 5, 177-.
69. Daniel H, Gholami AM, Berry D, Desmarchelier C, Hahne H, Loh G, Mondot S, Lepage P, Rothballer M, Walker A, BohmC, Wenning M, Wagner M, Blaut M, Schmitt-Kopplin P, Kuster B, Haller D, Clavel T (2014) High-fat diet alters gut microbiota physiology in mice. ISME J 8, 295-308.
70. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI (2009) The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1, 6ra14.